Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

 412.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 445.00p
  • 52 Week Low: 166.80p
  • Currency: UK Pounds
  • Shares Issued: 105.92m
  • Volume: 127,284
  • Market Cap: £436.93m
  • RiskGrade: 125
  • Beta: 1.21

Latest ShareCast News

Oxford Biomedica reports first-half revenue growth

By Josh White

Date: Monday 23 Sep 2024

(Sharecast News) - Oxford Biomedica, a prominent gene and cell therapy company, reported significant revenue growth alongside strategic advancements in its interim results on Monday.

OXB ShareCast News

Oxford Biomedica still expecting small loss afte... 08-Aug-2024 ShareCast
Oxford Biomedica appoints new finance chief 17-Jul-2024 ShareCast
Oxford Biomedica confident as it moves away from... 29-Apr-2024 ShareCast
Oxford Biomedica shares rise on post-acquisition... 05-Mar-2024 ShareCast
Director dealings: TUI, Oxford Biomedica board m... 27-Sep-2023 ShareCast

OXB Regulatory News

Board Changes 18-Nov-2024 07:00 RNS
Grant of options 05-Nov-2024 14:23 RNS
Holding(s) in Company 04-Nov-2024 10:56 RNS
Total Voting Rights 01-Nov-2024 07:00 RNS
Holding(s) in Company 31-Oct-2024 07:00 RNS

OXB Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ... 16-Aug-2008 Times
Need to know 10-May-2008 Times
DSG International may be losing its spark 12-Feb-2008 Telegraph
Oxford BioMedica clinches $690m licensing deal f... 29-Mar-2007 The Independent
Oxford Biomedica seals €518m deal with Sanofi ov... 29-Mar-2007 Times

OXB Tips & Analysis

FTSE 100 latest: Oil falls take shares lower 06-Jul-2009 Daily Mail
The Investment Column: Oxford Biomedica 11-Mar-2008 The Independent
Jetion could benefit from Spanish election 11-Mar-2008 Times
The Week Ahead: Kazakh and Tate & Lyle head for ... 10-Mar-2008 The Independent
Market Report: Prudential driven up on Chinese b... 06-Mar-2008 The Independent

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 412.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 445.00p
52 Week Low 166.80p
Volume 127,284
Shares Issued 105.92m
Market Cap £436.93m
Beta 1.21
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.27% below the market average32.27% below the market average32.27% below the market average32.27% below the market average32.27% below the market average
8.00% above the sector average8.00% above the sector average8.00% above the sector average8.00% above the sector average8.00% above the sector average
Price Trend
85.18% above the market average85.18% above the market average85.18% above the market average85.18% above the market average85.18% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
52.28% below the market average52.28% below the market average52.28% below the market average52.28% below the market average52.28% below the market average
52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average52.94% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 5
Sell 0
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:29 21 @ 413.50p
16:29 444 @ 413.50p
16:26 850 @ 412.60p
16:21 42 @ 413.50p
16:21 1,000 @ 413.00p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page